Donghoon Yoon

Associate Professor

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

17 h-index 144 pubs 1,228 cited

Research Areas

Cancer-related molecular mechanisms research Lymphoma Diagnosis and Treatment Multiple Myeloma Research and Treatments Drug-Induced Hepatotoxicity and Protection Nanoparticle-Based Drug Delivery Bone Metabolism and Diseases Head and Neck Cancer Studies Cancer Treatment and Pharmacology

Links

ORCID Lab Website UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Donghoon Yoon, an Associate Professor in Internal Medicine at the University of Arkansas for Medical Sciences, studies molecular mechanisms underlying diseases and develops therapeutic strategies. His research has explored the role of 7-dehydrocholesterol in inducing endoplasmic reticulum stress and apoptosis in head and neck squamous cell carcinoma, and he has investigated NEK2 as a therapeutic target for lymphoma. Yoon's work also involves the development of animal models for diseases such as multiple myeloma bone disease and diffuse large B cell lymphoma. Additionally, his publications indicate research into advancements in drug delivery systems, including the fabrication and application of solid microneedles for synchronized dual-drug delivery. Yoon has authored 144 publications, accumulating 1,228 citations, and holds an h-index of 17. He collaborates extensively with researchers at his institution, including Syed Hassan Mehdi, Ying-Zhi Xu, Samantha Kendrick, and Vijay Patel.

Metrics

h-index: 17
Publications: 144
Citations: 1,228

Selected Publications

The role of 7-dehydrocholesterol in inducing ER stress and apoptosis of head and neck squamous cell carcinoma (2025) DOI
Self-Assembly of Microstructured Protein Coatings with Programmable Functionality for Fluorescent Biosensors (2024) DOI
Development of New Diffuse Large B Cell Lymphoma Mouse Models (2024) DOI
Advancing Drug Delivery with Pocket Microneedle Achieving Dual-Drug Synchronization (2024) DOI
The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression (2023) DOI
Abstract 3828: Herbal extracts from lycii radicis corex and achyranthes japonica prevent multiple myeloma progression (2023) DOI
Experimental Validation of Diffraction Lithography for Fabrication of Solid Microneedles (2022) DOI
Abstract 1655: Development of humanized diffuse large B-cell lymphoma mouse models (2022) DOI
Development of Humanized Diffuse Large B-Cell Lymphoma Mouse Models (2021) DOI
Herbal Extracts from Lycii Radicis Corex and Achyranthes japonica Prevent Multiple Myeloma (2021) DOI
An Improved Animal Model of Multiple Myeloma Bone Disease (2021) DOI
Animal Models of Multiple Myeloma Bone Disease (2021) DOI

Grants & Funding

Study of Sigma Anti-Bonding Calcium (SAC) Role(s) in Multiple Myeloma and Cutaneous Wound Healing Calcium & Bone Health Institute Principal Investigator
In Situ Imaging of Collagen Degradation Activity in Multiple Myeloma and Fibrosis Murine Models - Resubmission NIH/Office of the Director - Pass Through: University of Utah Principal Investigator
Study of Sigma Anti-Bonding Calcium (SAC) Role(s) in Multiple Myeloma and Erythropoietin-Induced Osteoporosis Calcium & Bone Health Institute Principal Investigator
Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine U.S. Food and Drug Administration - Pass Through: Arkansas Research Alliance Co-Investigator
Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Select